ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action.

Alaa Elmetwalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.